BACKGROUND: Human metapneumovirus (hMPV) causes lower respiratory tract infections, particularly in young children and the elderly. METHODS: A prospective study was conducted on the clinical characteristics of infants <2 years of age admitted to hospital for respiratory infection and the characteristics of hMPV infections were compared with those of infections caused by respiratory syncytial virus (RSV). Influenza A, B and C viruses, RSV, parainfluenza viruses, and adenoviruses were simultaneously detected in clinical samples by multiple reverse transcription nested-PCR assay. The presence of hMPV was tested in all samples using two separate RT-PCR tests. RESULTS: A respiratory virus was detected in 65.9% of the 749 children included in the study. hMPV, found in 69 of the positive nasopharyngeal aspirates (14%), was the most common virus after RSV. Peak incidence was in March and over 80% of children were <12 months of age. The most common diagnoses were recurrent wheezing (49.3%) and bronchiolitis (46.4%). Oxygen therapy was required by 58% of patients, and assisted ventilation by one. Clinical characteristics in the 18 co-infections were indistinguishable from those of single infections. Fifty one hMPV single infections were compared with 88 hRSV single infections. Recurrent wheezing was diagnosed more frequently in hMPV patients. All other variables tested were similar in both groups. CONCLUSIONS: hMPV was the second most frequent virus after RSV in infants <2 years of age hospitalised for respiratory infection and was associated with lower respiratory tract infections. hMPV occurred predominantly in springtime. Co-infections were frequent and clinically similar to single infections and RSV infections.
BACKGROUND:Human metapneumovirus (hMPV) causes lower respiratory tract infections, particularly in young children and the elderly. METHODS: A prospective study was conducted on the clinical characteristics of infants <2 years of age admitted to hospital for respiratory infection and the characteristics of hMPV infections were compared with those of infections caused by respiratory syncytial virus (RSV). Influenza A, B and C viruses, RSV, parainfluenza viruses, and adenoviruses were simultaneously detected in clinical samples by multiple reverse transcription nested-PCR assay. The presence of hMPV was tested in all samples using two separate RT-PCR tests. RESULTS: A respiratory virus was detected in 65.9% of the 749 children included in the study. hMPV, found in 69 of the positive nasopharyngeal aspirates (14%), was the most common virus after RSV. Peak incidence was in March and over 80% of children were <12 months of age. The most common diagnoses were recurrent wheezing (49.3%) and bronchiolitis (46.4%). Oxygen therapy was required by 58% of patients, and assisted ventilation by one. Clinical characteristics in the 18 co-infections were indistinguishable from those of single infections. Fifty one hMPV single infections were compared with 88 hRSV single infections. Recurrent wheezing was diagnosed more frequently in hMPVpatients. All other variables tested were similar in both groups. CONCLUSIONS:hMPV was the second most frequent virus after RSV in infants <2 years of age hospitalised for respiratory infection and was associated with lower respiratory tract infections. hMPV occurred predominantly in springtime. Co-infections were frequent and clinically similar to single infections and RSV infections.
Authors: John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe Journal: N Engl J Med Date: 2004-01-29 Impact factor: 91.245
Authors: Bernadette G van den Hoogen; Gerard J J van Doornum; John C Fockens; Jan J Cornelissen; Walter E P Beyer; Ronald de Groot; Albert D M E Osterhaus; Ron A M Fouchier Journal: J Infect Dis Date: 2003-10-27 Impact factor: 5.226
Authors: Luis E Cuevas; Abubaker M Ben Nasser; Winifred Dove; Ricardo Q Gurgel; Julie Greensill; C Anthony Hart Journal: Emerg Infect Dis Date: 2003-12 Impact factor: 6.883
Authors: María L García García; C Calvo Rey; F Martín del Valle; M R López Huertas; I Casas Flecha; R Díaz-Delgado; P Pérez-Breña Journal: An Pediatr (Barc) Date: 2004-09 Impact factor: 1.500
Authors: Frank Esper; Richard A Martinello; Derek Boucher; Carla Weibel; David Ferguson; Marie L Landry; Jeffrey S Kahn Journal: J Infect Dis Date: 2004-04-02 Impact factor: 5.226
Authors: Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen Journal: Clin Microbiol Rev Date: 2011-10 Impact factor: 26.132
Authors: Ali Mohammed Alsuheel; Abdelwahid Saeed Ali; Ahmed Musa Al-Hakami; Ayed Abdullah Shati; Harish C Chandramoorthy; Saleh Mohammed Al-Qahtani Journal: Saudi J Med Med Sci Date: 2019-04-12
Authors: Ignacio A Echenique; Philip A Chan; Kimberle C Chapin; Sarah B Andrea; Joseph L Fava; Leonard A Mermel Journal: PLoS One Date: 2013-04-09 Impact factor: 3.240
Authors: Sandra A Asner; Michelle E Science; Dat Tran; Marek Smieja; Arnaud Merglen; Dominik Mertz Journal: PLoS One Date: 2014-06-16 Impact factor: 3.240
Authors: Silvia Ricart; Maria Angeles Marcos; Marta Sarda; Andres Anton; Carmen Muñoz-Almagro; Tomas Pumarola; Marti Pons; Juan Jose Garcia-Garcia Journal: Pediatr Pulmonol Date: 2012-09-04